Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

0.9532
Delayed Data
As of 4:00pm ET
 -0.0568 / -5.62%
Today’s Change
0.67
Today|||52-Week Range
2.35
-21.22%
Year-to-Date
No recent news for Antares Pharma Inc.

Today’s Trading

Previous close1.01
Today’s open0.97
Day’s range0.92 - 0.99
Volume15,399,227
Average volume (3 months)811,480
Market cap$159.6M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+48.15%
Earnings growth (this year)--
Earnings growth (next 5 years)+54.50%
Revenue growth (last year)+72.28%
P/E ratioNM
Price/Sales3.88
Price/Book2.38

Competitors

 Today’s
change
Today’s
% change
TRXCTransenterix Inc-0.09-6.47%
CVRSCorindus Vascular Ro...0.000.00%
AVGRAvinger Inc+0.62+5.37%
SQNMSequenom Inc-0.06-5.04%
Data as of 4:14pm ET, 06/24/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$45.7M
Annual profit (last year)-$20.7M
Net profit margin-45.25%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Robert F. Apple
Chief Financial Officer &
Senior Vice President
James E. Fickenscher
Corporate headquarters
Ewing, New Jersey

Forecasts

Partner Offers

Search for Jobs